Co-Diagnostics (NASDAQ: CODX) announced that its Indian joint venture, CoSara Diagnostics Pvt. Ltd., has signed an agreement to expand its commercial and distribution territory across South Asia to include Bangladesh, Pakistan, Nepal and Sri Lanka, significantly increasing its addressable market to an estimated $13.0 billion. The expansion supports planned commercialization of the CoSara PCR Pro(R) point-of-care platform and SARAGENE(R) product line, subject to regulatory […]

Perpetuals.com (NASDAQ: PDC) announced that CEO Patrick Gruhn will present and host a live question-and-answer session at the Emerging Growth Conference on April 1, 2026, at 12:35 p.m. ET, where he is expected to discuss the company AI-powered financial services platform and engage with investors. To view the full press release, visit https://ibn.fm/EZgBf About Perpetuals.com Ltd. Perpetuals.com […]

Regulatory recognition from international health authorities can significantly shape the trajectory of emerging therapies worldwide, particularly in rare disease development where clinical pathways are often complex and resource intensive. Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases and unmet medical needs, recently received such recognition as its investigational therapy SGX945 […]

Pelican Acquisition (NASDAQ: PELI) announced that shareholders approved its proposed business combination with Pelican Holdco Inc., Greenland Exploration Limited and March GL Company at an extraordinary general meeting held March 19, 2026, with closing of the transaction expected on or about March 24, 2026. The deal is intended to form a publicly traded energy company […]

Safe Pro Group (NASDAQ: SPAI) is a technology company delivering advanced security and defense solutions to customers in government and industry, such as homeland security, law enforcement, defense, humanitarian, and commercial markets. The company is addressing the global multi-billion dollar need for scalable defense, demining, and public safety solutions. Safe Pro Group has three business […]

Black Hawk Acquisition (Nasdaq: BKHA, BKHAU, BKHAR) announced that its proposed de-SPAC acquisition target, Vesicor Therapeutics Inc., has appointed Michael Tolentino, M.D., as chief executive officer effective March 17, 2026, succeeding founder Luo Feng, Ph.D., who will transition to chief scientific officer as the company advances its p53-based cancer therapeutic platform and prepares for IND-enabling studies and a […]

Experts working across oncology are exploring how different treatment approaches can work together to improve outcomes for cancer patients. One area drawing significant attention involves combining immunotherapy with chemotherapy to help the immune system better recognize and attack tumors. LIXTE Biotechnology Holdings (NASDAQ: LIXT) is working within this emerging field through the development of its […]

ParaZero Technologies (NASDAQ: PRZO) announced the signing of a strategic cooperation agreement with India-based BonV Aero to market its portfolio of counter-UAS solutions, led by the DefendAir system, a mobile, net-based interception platform designed for rapid deployment against hostile drones, while also enabling future configurations and integrations. The companies have already conducted a live demonstration […]

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on rare diseases, announced that a comprehensive summary of clinical trials evaluating HyBryte(TM) (synthetic hypericin) for cutaneous T-cell lymphoma has been published in the peer-reviewed journal Expert Opinion on Investigational Drugs, highlighting the therapy’s safety profile, non-mutagenic mechanism and demonstrated efficacy across studies, while supporting its potential as a first-line treatment […]

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on rare diseases, was featured in the latest BioMedWire Podcast episode where CEO Christopher Schaber discussed the upcoming interim analysis of the Phase 3 FLASH2 study evaluating HyBryte(TM) for cutaneous T-cell lymphoma, noting strong blinded aggregate response rates above initial assumptions and outlining potential outcomes including early study completion or continued enrollment, while […]

Disseminated on behalf of Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) and may include paid advertising. As geopolitical tensions reshape global supply chains, critical minerals have become integral to economic and national security. Trilogy Metals (NYSE American: TMQ) (TSX: TMQ) is becoming increasingly aligned with this shift, as the U.S. Administration ramps up efforts to counter foreign dominance, […]

Forward Industries (NASDAQ: FWDI), the leading Solana treasury company, announced it has entered into a privately negotiated agreement to repurchase 6,164,324 shares for $27.4 million, reducing shares outstanding and increasing SOL-per-share to 0.0662 following the transaction, which is being financed through a $40 million digital currency loan agreement with Galaxy Digital secured by treasury assets […]